ExxonMobil
XOM
$149.56
+0.12%
Exxon Mobil Corporation is a global integrated oil and gas giant engaged in the exploration, production, refining, and marketing of petroleum products, as well as the manufacturing of commodity and specialty chemicals. It is a dominant market leader with a massive scale, evidenced by its 4.1 million barrels per day of global refining capacity and 19.3 billion barrels of oil equivalent reserves. The current investor narrative is dominated by the interplay between sustained high oil prices, driven by geopolitical supply constraints, and the stock's recent pullback from its highs, as the market debates the durability of the energy supercycle and Exxon's ability to maintain its robust cash generation and shareholder returns in this volatile price environment.…
XOM
ExxonMobil
$149.56
Related headlines
Investment Opinion: Should I buy XOM Today?
Rating & Thesis: Hold. ExxonMobil is a high-quality, defensive energy giant with a strong balance sheet and shareholder returns, but its current valuation fairly reflects near-term cyclical pressures and oil price uncertainty, warranting a neutral stance pending clearer catalysts.
Supporting Evidence: The stock trades at a reasonable forward P/E of 13.64x, a 24.5% discount to its trailing multiple, suggesting the market has priced in moderating earnings. It offers a solid 3.3% dividend yield supported by $23.61B in TTM free cash flow and a payout ratio of 59.7%. However, revenue growth has turned negative (-1.26% YoY in Q4), and profitability is compressing, with gross margin down 354 basis points sequentially. The implied analyst target of ~$168 offers 15.6% upside, but this is contingent on a rebound in commodity prices and operational execution.
Risks & Conditions: The two biggest risks are a sustained drop in oil prices eroding cash flow and further margin compression in downstream/chemicals. This Hold rating would upgrade to a Buy if the forward P/E compressed below 12x (offering a greater margin of safety) or if quarterly revenue growth re-accelerates above 5% YoY. It would downgrade to a Sell if free cash flow fell below $15B annually, threatening the dividend, or if the stock broke below key technical support near $140. Relative to its history and the current macro backdrop, XOM is fairly valued, not cheap enough for aggressive accumulation nor expensive enough to warrant selling.
Sign up to view all
XOM 12-Month Price Forecast
ExxonMobil presents a classic GARP (Growth at a Reasonable Price) case with a defensive tilt. The forward valuation is sensible, and the financial foundation is rock-solid. However, near-term fundamentals are softening, and the stock lacks a clear near-term catalyst for a major breakout. The neutral stance reflects this balance: significant upside requires a bullish oil price move, while the downside is protected by the dividend and low volatility. We would upgrade to bullish if quarterly revenue growth turns positive and operating margins stabilize above 11%. A break below $140 on sustained volume would trigger a downgrade to bearish.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on ExxonMobil's 12-month outlook, with a consensus price target around $194.43 and implied upside of +30.0% versus the current price.
Average Target
$194.43
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$120 - $194
Analyst target range
Analyst coverage for ExxonMobil is extensive among major institutions, with a recent pattern of reiterated 'Overweight' and 'Hold' ratings indicating a stable, consensus bullish-to-neutral view. The average analyst target price is not explicitly provided in the dataset, but the estimated EPS average for the forward period is $12.34, which, when combined with the forward PE of 13.64x, implies a potential price target in the $168 range, suggesting meaningful upside from the current $145.26 price. The target range, inferred from estimated EPS lows of $10.47 and highs of $14.46, is wide, reflecting uncertainty around commodity price trajectories and margin outcomes; the high end assumes sustained high oil prices and operational excellence, while the low end incorporates risks of a sharp economic slowdown or geopolitical resolution that crashes oil prices.
Bulls vs Bears: XOM Investment Factors
The investment debate for ExxonMobil centers on the tension between its defensive financial fortress and its cyclical exposure to volatile commodity prices. The bull case is supported by robust cash generation, an attractive forward valuation, and a low-beta defensive profile. The bear case highlights a premium historical valuation, recent margin compression, and acute sensitivity to oil price swings. Currently, the bull side holds stronger evidence due to the concrete metrics of substantial free cash flow ($23.61B), a strong balance sheet (D/E 0.17), and a forward P/E (13.64x) that prices in reasonable growth. The single most important factor is the trajectory of oil prices; a sustained drop below levels that support current cash flows would invalidate the bullish thesis, while a rebound could reignite the uptrend toward the $168 implied target.
Bullish
- Robust Cash Flow & Shareholder Returns: Exxon generated $23.61 billion in trailing twelve-month free cash flow, funding a substantial 3.3% dividend yield and share buybacks. This fortress financial position, with a low debt-to-equity ratio of 0.17, provides a defensive cushion and reliable income stream for investors.
- Attractive Forward Valuation: The stock trades at a forward P/E of 13.64x, a significant discount to its trailing P/E of 18.07x, implying the market expects earnings growth. This forward multiple is reasonable for a company of its scale and stability, especially when combined with an EV/EBITDA of 8.16x.
- Defensive Low-Beta Profile: With a beta of 0.183, XOM exhibits dramatically lower volatility than the broader market, behaving more like a defensive staple. This characteristic provides portfolio stability, as evidenced by its 41.45% 1-year return outperforming the S&P 500 by over 13 percentage points despite recent pullbacks.
- Analyst Implied Upside: Using the forward P/E of 13.64x and the consensus estimated EPS of $12.34, the implied analyst price target is approximately $168. This represents a potential 15.6% upside from the current price of $145.26, suggesting the stock is undervalued relative to forward earnings expectations.
Bearish
- Premium Historical Valuation: The trailing P/E of 18.07x sits above the company's own historical average (often in the low-to-mid teens), indicating the stock is trading at a premium to its own history. This leaves less margin for error and increases vulnerability to multiple compression if earnings disappoint.
- Recent Profitability Compression: Q4 2025 net income fell to $6.50 billion from $7.55 billion in Q3, and gross margin compressed to 18.89% from 22.43%. This sequential decline highlights the cyclical pressure on downstream and chemical margins, questioning the durability of peak earnings.
- Revenue Deceleration & Oil Price Sensitivity: Q4 2025 revenue of $80.04 billion declined 1.26% year-over-year, continuing a sequential downtrend. The stock's recent 6.08% monthly drop coincided with news of a 5% oil price plunge on geopolitical de-escalation hopes, underscoring its fundamental sensitivity to volatile commodity prices.
- Technical Correction from Highs: Trading at 58% of its 52-week range ($101.19 to $176.41), XOM has retreated significantly from its highs. Recent momentum is negative, with the stock down 4.75% over three months, suggesting a potential consolidation or trend reversal as the market digests prior gains.
XOM Technical Analysis
The stock is in a sustained long-term uptrend but has recently entered a corrective phase. Over the past year, XOM has delivered a strong 41.45% price appreciation, yet as of the latest close at $145.26, it is trading at approximately 58% of its 52-week range ($101.19 to $176.41), indicating a significant retreat from its highs and positioning it in a middle-ground that reflects both the prior bullish momentum and recent profit-taking. Recent momentum has turned sharply negative, diverging from the longer-term uptrend, with the stock down 6.08% over the past month and 4.75% over the past three months, suggesting a potential consolidation or short-term trend reversal as the market digests its earlier gains. Key technical support is at the 52-week low of $101.19, while immediate overhead resistance is at the 52-week high of $176.41; a breakdown below recent lows near $145 could signal a deeper correction, while a reclaim of the $170+ level would reassert the bullish trend. With a beta of 0.183, the stock exhibits dramatically lower volatility than the broader market (SPY), behaving more like a defensive staple than a typical energy stock, which is a critical consideration for portfolio risk management and sector allocation.
Beta
0.18
0.18x market volatility
Max Drawdown
-15.7%
Largest decline past year
52-Week Range
$102-$176
Price range past year
Annual Return
+45.1%
Cumulative gain past year
| Period | XOM Return | S&P 500 |
|---|---|---|
| 1m | -2.1% | +5.4% |
| 3m | -0.2% | +10.9% |
| 6m | +27.7% | +11.0% |
| 1y | +45.1% | +28.1% |
| ytd | +21.9% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
XOM Fundamental Analysis
Revenue has shown stability with a slight recent deceleration; the most recent Q4 2025 revenue was $80.04 billion, representing a year-over-year decline of 1.26%, and the sequential trend from Q3's $83.33 billion indicates moderating top-line growth, largely tied to fluctuating commodity prices. The company remains highly profitable, with Q4 2025 net income of $6.50 billion and a gross margin of 18.89%, though profitability has compressed from the prior quarter's net income of $7.55 billion and gross margin of 22.43%, reflecting the cyclical pressures on downstream and chemical margins. Financially, Exxon is exceptionally strong, boasting a low debt-to-equity ratio of 0.17, robust trailing twelve-month free cash flow of $23.61 billion, and a Return on Equity of 11.12%, indicating a fortress balance sheet that funds substantial shareholder returns and internal investments without reliance on external financing.
Quarterly Revenue
$80.0B
2025-12
Revenue YoY Growth
-0.01%
YoY Comparison
Gross Margin
+0.18%
Latest Quarter
Free Cash Flow
$23.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is XOM Overvalued?
Given its substantial net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. Exxon's trailing PE is 18.07x, while its forward PE is notably lower at 13.64x, indicating the market expects earnings growth in the coming year. Compared to sector averages, Exxon's valuation presents a mixed picture; its trailing PE of 18.07x is above the typical integrated oil major range, but its forward multiple suggests a discount to growth expectations, while its Price-to-Sales ratio of 1.61x and EV/EBITDA of 8.16x are generally in line with or below historical sector norms for a company of its stability. Historically, the current trailing PE of 18.07x sits above its own multi-year average visible in the data (often in the low-to-mid teens), suggesting the stock is trading at a premium to its own history, which prices in a favorable commodity price environment and disciplined capital return, leaving less margin for error if fundamentals deteriorate.
PE
18.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~22x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Exxon's primary financial risk is earnings volatility driven by commodity prices, as evidenced by the 13.9% sequential decline in Q4 net income. While the balance sheet is strong with a debt-to-equity ratio of 0.17, revenue concentration in oil & gas exposes the company to secular demand risks from the energy transition. Margin pressure is a clear operational risk, with gross profit falling from $18.69B in Q3 to $15.12B in Q4, indicating downstream and chemical segments are facing cyclical headwinds that could persist.
Market & Competitive Risks: The stock trades at a trailing P/E of 18.07x, a premium to its own historical average, creating valuation compression risk if the 'energy supercycle' narrative fades. The stock's low beta of 0.183 suggests it is not fully correlated with energy sector rallies, potentially limiting upside in a bullish oil environment. Competitive and regulatory risks are heightened by the energy transition, with recent news highlighting NextEra Energy's massive acquisition to dominate the AI-powered utility space, representing a strategic shift Exxon must navigate.
Worst-Case Scenario: The worst-case scenario involves a sharp, sustained collapse in oil prices due to geopolitical resolution (e.g., Iran truce) combined with a global economic slowdown that crushes demand. This would compress refining and chemical margins further, leading to significant earnings misses and dividend sustainability concerns. In this adverse scenario, the stock could realistically revisit its 52-week low of $101.19, representing a potential downside of approximately -30% from the current price of $145.26. The wide analyst EPS low estimate of $10.47 supports this bearish outcome.
FAQ
The key risks are: 1) Commodity Price Risk: Earnings are directly tied to volatile oil & gas prices, as seen in the recent 5% oil price drop on geopolitical news. 2) Margin Compression: Sequential declines in gross margin (from 22.43% to 18.89%) and net income signal cyclical pressure. 3) Secular/Demand Risk: The long-term energy transition threatens the core business model. 4) Valuation Risk: The trailing P/E of 18.07x is at a historical premium, leaving room for multiple contraction if growth stalls. Of these, near-term commodity price volatility and margin trends pose the most immediate risks.
Our 12-month forecast outlines three scenarios. The Base Case (55% probability) sees the stock trading between $145 and $168, driven by stable oil prices and execution on the $12.34 consensus EPS estimate. The Bull Case (30% probability) targets $168 to $176, requiring a sustained oil price rally and margin recovery. The Bear Case (15% probability) warns of a drop to between $101 and $140 if oil prices collapse. The Base Case is most likely, anchored by Exxon's defensive financials, but the wide range reflects high dependency on unpredictable commodity markets.
XOM's valuation presents a mixed picture. It is trading at a premium to its own historical average, with a trailing P/E of 18.07x above its typical low-to-mid teens range. However, its forward P/E of 13.64x suggests the market expects earnings growth and offers a more reasonable entry. Compared to sector peers, its EV/EBITDA of 8.16x and P/S of 1.61x are generally in line. Overall, the stock is fairly valued relative to its current fundamentals and the uncertain commodity price outlook; it is not deeply undervalued nor egregiously overvalued.
XOM is a good buy for income-focused, risk-averse investors seeking stability and a 3.3% dividend yield backed by strong cash flow. The forward P/E of 13.64x offers reasonable value, and the low beta of 0.183 provides defensive characteristics. However, for growth-oriented investors, the recent revenue deceleration and oil price sensitivity present headwinds. It is a good buy under the condition that an investor's goal is reliable income and portfolio diversification, not explosive growth, and they are comfortable with the inherent commodity cycle volatility.
XOM is primarily suitable for long-term investment. Its low beta (0.183) and high dividend yield (3.3%) are characteristics that benefit from compounding over time. The company's massive scale and integrated model are built for longevity, not quick trades. Short-term trading is challenged by the stock's low volatility and sensitivity to unpredictable oil price headlines. A minimum holding period of 3-5 years is recommended to ride through commodity cycles and fully benefit from the dividend reinvestment and the company's capital return program.
